See more : Sindhu Trade Links Limited (SINDHUTRAD.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Yamashita Health Care Holdings,Inc. (9265.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yamashita Health Care Holdings,Inc., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) Income Statement Analysis – Financial Results
- Newag S.A. (NWG.WA) Income Statement Analysis – Financial Results
- LQwD FinTech Corp. (LQWD.V) Income Statement Analysis – Financial Results
- LXP Industrial Trust (LXP-PC) Income Statement Analysis – Financial Results
- Ovintiv Inc. (OVV) Income Statement Analysis – Financial Results
Yamashita Health Care Holdings,Inc. (9265.T)
About Yamashita Health Care Holdings,Inc.
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 61.56B | 58.20B | 55.15B | 70.13B | 64.66B | 61.53B | 58.69B | 52.52B | 51.62B | 50.31B | 51.05B | 47.13B |
| Cost of Revenue | 53.25B | 50.15B | 47.42B | 62.62B | 57.85B | 55.03B | 52.38B | 46.94B | 45.81B | 44.48B | 44.84B | 41.53B |
| Gross Profit | 8.30B | 8.05B | 7.72B | 7.51B | 6.81B | 6.51B | 6.31B | 5.58B | 5.80B | 5.83B | 6.21B | 5.60B |
| Gross Profit Ratio | 13.49% | 13.83% | 14.01% | 10.71% | 10.53% | 10.57% | 10.75% | 10.63% | 11.24% | 11.60% | 12.15% | 11.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.94B | 934.00M | 921.25M | 862.08M | 834.51M | 794.01M | 811.00M | 5.13B | 4.97B | 4.95B | 5.03B | 4.76B |
| Selling & Marketing | 344.00M | 329.00M | 310.00M | 294.00M | 285.00M | 271.00M | 292.00M | 263.00M | 248.00M | 220.00M | 191.00M | 170.00M |
| SG&A | 7.33B | 934.00M | 921.25M | 862.08M | 834.51M | 794.01M | 811.00M | 5.39B | 5.22B | 5.17B | 5.22B | 4.93B |
| Other Expenses | 0.00 | 50.00M | 57.66M | 52.56M | 64.53M | 70.09M | 58.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.33B | 6.89B | 6.79B | 6.54B | 6.24B | 5.98B | 5.94B | 5.39B | 5.22B | 5.21B | 5.39B | 5.02B |
| Cost & Expenses | 60.59B | 57.03B | 54.22B | 69.16B | 64.10B | 61.01B | 58.32B | 52.33B | 51.03B | 49.69B | 50.23B | 46.55B |
| Interest Income | 10.00M | 9.00M | 2.15M | 1.80M | 196.00K | 1.73M | 7.92M | 1.00M | 3.00M | 4.00M | 5.00M | 3.00M |
| Interest Expense | 0.00 | 2.00M | 3.86M | 4.18M | 2.45M | 3.38M | 6.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 213.00M | 203.00M | 221.62M | 198.28M | 190.91M | 211.33M | 215.87M | 166.20M | 128.25M | 139.00M | 167.00M | 164.00M |
| EBITDA | 1.09B | 1.36B | 1.25B | 1.25B | 833.23M | 596.71M | 589.53M | 352.00M | 713.00M | 678.00M | 1.00B | 813.78M |
| EBITDA Ratio | 1.76% | 2.43% | 2.23% | 1.75% | 1.30% | 1.35% | 1.15% | 0.67% | 1.38% | 1.35% | 1.97% | 1.47% |
| Operating Income | 968.00M | 1.16B | 930.75M | 968.84M | 560.53M | 522.32M | 373.29M | 186.65M | 584.75M | 539.00M | 837.00M | 528.00M |
| Operating Income Ratio | 1.57% | 1.99% | 1.69% | 1.38% | 0.87% | 0.85% | 0.64% | 0.36% | 1.13% | 1.07% | 1.64% | 1.12% |
| Total Other Income/Expenses | -97.00M | -521.00M | 96.00M | 82.71M | 81.80M | -140.31M | -6.45M | -78.11M | 41.43M | 89.00M | -14.00M | 120.93M |
| Income Before Tax | 871.00M | 635.00M | 1.03B | 1.05B | 642.33M | 382.01M | 366.84M | 108.54M | 626.18M | 627.00M | 823.00M | 587.00M |
| Income Before Tax Ratio | 1.41% | 1.09% | 1.86% | 1.50% | 0.99% | 0.62% | 0.63% | 0.21% | 1.21% | 1.25% | 1.61% | 1.25% |
| Income Tax Expense | 293.00M | 423.00M | 330.02M | 373.06M | 182.63M | 237.58M | 145.77M | 87.81M | 294.03M | 268.00M | 270.00M | 266.00M |
| Net Income | 580.00M | 219.00M | 696.00M | 678.49M | 459.70M | 144.42M | 220.61M | 19.41M | 332.24M | 359.00M | 553.00M | 321.00M |
| Net Income Ratio | 0.94% | 0.38% | 1.26% | 0.97% | 0.71% | 0.23% | 0.38% | 0.04% | 0.64% | 0.71% | 1.08% | 0.68% |
| EPS | 227.83 | 85.79 | 272.67 | 265.77 | 180.07 | 56.57 | 87.04 | 7.75 | 131.46 | 140.67 | 216.68 | 125.78 |
| EPS Diluted | 227.83 | 85.79 | 272.67 | 265.77 | 180.07 | 56.57 | 87.04 | 7.75 | 131.46 | 140.67 | 216.68 | 125.78 |
| Weighted Avg Shares Out | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | 2.53M | 2.51M | 2.53M | 2.55M | 2.55M | 2.55M |
| Weighted Avg Shares Out (Dil) | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | 2.53M | 2.51M | 2.53M | 2.55M | 2.55M | 2.55M |
Source: https://incomestatements.info
Category: Stock Reports